All News

KOA can not only ⬆️ morbidity, it also ⬆️s mortality - long term data from OAI - 5K pts, f/u 9 yrs . Greater KL scores (worse Xrays) - greater mortality! #ACR21 abst#1028 @RheumNow https://t.co/jREmbEN2Ae
Bella Mehta bella_mehta ( View Tweet)
Exercise does not cause objective signs of increased disease activity in PsA ⭐️11 weeks of High Intensity Interval Training in PsA pts did not show worsening changes in MRI SI joint bone marrow edema. Abs#1362 @RheumNow #ACRBest https://t.co/A3aOEy8Wz0 https://t.co/arPvjsbudm

Links:

Robert B Chao, MD doctorRBC ( View Tweet)
Clinical Pearl from Dr. @JKolfenbach ⭐️AAV doesn't typically cause hard palate lesions Instead, consider: ➡️Cocaine-induced midline destructive lesion ➤try to send human neutrophil elastase ab (+ in cocaine use but not in AAV) ➡️Malignancy (NK T-cell lymphoma) #ACR21 @RheumNow https://t.co/KIEXgCR23c
Meral K. El Ramahi, MD MeralElRamahiMD ( View Tweet)
TNFi vs tofacitinib drug survival in RA (based on two Canadian registries, PS adjusted) This seems to be my refrain this ACR: 'TNF inhibitors: let's not forget, they're quite good' #ACR21 ABST1217 @RheumNow @Janetbirdope https://t.co/MyFc6do0JL
David Liew drdavidliew ( View Tweet)
Dr Koster @MdWarrington @AliDuarteMD open label study baricitinib in relapsing GCA. Well-tolerated and allowed GC discontinuation by 24 weeks in most patients. Encouraging, we need an RCT! Abstr#1396 #ACR21 @RheumNow https://t.co/N2h54MHpIq
Richard Conway RichardPAConway ( View Tweet)
FDA update: Voclosporin Safety in #SLE RCTs #ACR21 https://t.co/xWCBELxQIc
Dr. John Cush RheumNow ( View Tweet)
FDA Safety Update - Dr. Nadia Habal reviewed approval of Voclosporin, anifrolumab, Avacopen and approved new indications for multiple drugs #ACR21 https://t.co/lAgQ4d0h2m
Dr. John Cush RheumNow ( View Tweet)
FDA safety update: OA Stakeholder Workshop June 2021 - Congrats to FDA & AFfor tackling this LARGE unmet need- difficulty in determining benefit in OA (pain, structure, biomarkers?) -more research needed #ACR21 https://t.co/hCWU8OL0Le
Dr. John Cush RheumNow ( View Tweet)
FDA Update: 3 trials showing Efficacy of Tocilizumab in COVID 19: 1. RECOVERY - lower mortality 2. EMPACTA - Less progression to mech vent or death 3. REMDACTA & COVACTA - did not meet primary endpoints (but not contradictory) FDA Metanalysis of all 4 trials #ACR21 EUA 6/21 https://t.co/9yHu87KGej
Dr. John Cush RheumNow ( View Tweet)
FDA Update session: Proven Benefit of Baricitinib in Hospitalized COVID-19 from the ACT2 and COV-BARRIER Studies, showing it does not need to be given with Remdesivir (4 mg qd maz 14days) #ACR21 https://t.co/r6crPtu3ZH
Dr. John Cush RheumNow ( View Tweet)
FDA Update at #ACR21, Dr. Golding reviews the criteria for EUA - Emergency use authorization for new drugs (critically important during COVID-19) Session 8M115 https://t.co/DqmxEIdvWZ D https://t.co/6aQG8yP7RW

Links:

Dr. John Cush RheumNow ( View Tweet)
#ACR21 #Abstr1420 A study checking #COVID vaccine response in 90 #lupus pts and 20 HC: ⬇️Titres of Abs in SLE vs controls 💠Factors of poor response: On any DMARDs exc HCQ only (OR 15) and normal dsDNA 📢Important to pause DMARDs in stable SLE @RheumNow https://t.co/USovFkiCRb https://t.co/bn5CC0xRS9

Links:

Md Yuzaiful Md Yusof Yuz6Yusof ( View Tweet)
Guselkumab improves anaemia in PsA. Appears to correlate with CRP response, ie inflammatory effect. Anaemia resolution associated good outcomes, but many with good outcomes still anaemic. Abstr#1331 #ACR21 @RheumNow https://t.co/LL63Qc0nk5
Richard Conway RichardPAConway ( View Tweet)
"Managing comorbidities can really improve outcomes for our patients" @UnaMakris highlights the bio-psycho-social approach to multicomplexity and multimorbidity in our older patients with RA. #ACR21 @RheumNow https://t.co/TMLqoreogZ
Mrinalini Dey DrMiniDey ( View Tweet)
#ACR21 Gift of Gab https://t.co/R1e14UA0pQ Change habits through your words ⭐️Cost of inaction ⭐️Incremental change (ex ⬇️EtOH) ⭐️Follow the crowd! ⭐️Why not try? Good advice for persuading pts re behavior change, Rx adherence, smoking cessation, vax hesitancy, etc. @Rheumnow https://t.co/9Cd7hAafTr

Links:

Eric Dein ericdeinmd ( View Tweet)
Pain can affect so many aspects of life; Dr. @unamakris noted that pain in older adults increase risk for: 👉falls/fracture 👉depression/anxiety 👉suicide 👉impaired nutrition 👉sleep disturb 👉mobility issues 👉cognitive deficits 👉frailty 👉spousal distress #ACR21 @rheumnow https://t.co/LicBiTRRKn
TheDaoIndex KDAO2011 ( View Tweet)
This is a reassuring introduction to Dr. Janet Zeide's lecture on the Gift of Gab! 😊 Might need to remind myself of this more regularly😉 @RheumNow #ACR21 @rheumarhyme #publicspeaking https://t.co/AoOmFkQUBk
sheila RHEUMarampa ( View Tweet)
Study on enthesitis response to biologic Rx ⭐️TNFI caused a 2❎ 🔽mean ActiveMASEI score compared to secukinumab ⭐️ 🔽PASI and DLQI score more in TNFI than Secukinumab 🔰Superiority of TNFi versus secukinumab in regards to active enthesitis Abst#1356 #ACR21 @Rheumnow https://t.co/wdzMYmn8AJ
swethaann23 swethaann23 ( View Tweet)
Really love this slide from @UnaMakris on the "5Ms of #Ageing"- will be trying to apply this in the clinical setting. 📊#Multicomplexity 🧠#Mind 🚶#Mobility 💊#Medications 🎯#WhatMattersMost #ACR21 @RheumNow https://t.co/bCQN4VpyBP
Mrinalini Dey DrMiniDey ( View Tweet)
#ACR21 Life hack! Hate public speaking? Wiggle your toes! 🔥Burn and redirect your adrenaline 🦆Like a duck's feet moving underwater, appearing calm on the surface ❌❌Janet Zeide: "Do not picture your audience naked!" @Rheumnow

Eric Dein ericdeinmd ( View Tweet)

×